Dear Sir, The National Institutes of Health Stroke Scale (NIHSS) is the most widespread clinical scale used in patients presenting with acute ischemic stroke. However, this scale is not validated for intracerebral hemorrhage (ICH) and its role is not clear.
Recently, Finocchi et al. [1] showed that the admission NIHSS score correlates with mortality and functional outcome at 30-day and 3-month follow-ups, by testing 156 patients with ICH. They concluded that NIHSS assessment at admission is a reliable tool of clinical monitoring and correlates with mortality and functional outcome.
In the aim of validating Finocchi's results in a different cohort of patients with a longer follow-up, we have investigated 196 consecutive patients with primary ICH, recruited at the stroke unit of the "Alessandro Manzoni" Hospital (Lecco) from 1 October 2012 to 31 December 2015, comparing the NIHSS at the admission with the modified Rankin Scale (mRS) after 6 months.
As in the original work, Spearman's rank correlation coefficient analysis was performed. Sensitivity, specificity, global accuracy, and receiver operating characteristic (ROC) curves were computed, using the median score 10 as NIHSS cut-off and the score 3 as mRS cut-off, by using the ROC web-based calculator (www.jrocfit.org).
Twenty-four patients (12%) were lost at follow-up, so the final sample included 172 patients. Baseline patients' features and NIHSS scores are reported in Table 1 . The mean NIHSS score at admission was 12.4 with a median score of 10, higher than in Finocchi's cohort. The 6month global fatality rate was similar (32.6%). Mean mRS score at 6 months was 3.6 (± 2) with a median score (interquartile range) of 3 (2-6; score 6 = death). In patients whose NIHSS score at admission was within the first quartile (0-4), unfavorable outcome occurred in 9/45 cases (20%; odds ratio vs. the rest of the sample .07, CI .03-0.16, p < .01). In patients with a NIHSS score within the second quartile (5-10) in 25/44 cases (57%; odds ratio vs. the rest of the sample .69, CI .34-.1.39, p = .3, ns). For NIHSS scores within the third quartile (11-20) in 42/49 cases (86%; odds ratio vs. the rest of the sample 5, CI 2-12, p < .01). Finally, for NIHSS scores within the fourth quartile (21-32), unfavorable outcome occurred in 33/34 cases (97%; odds ratio vs. the rest of the sample 26.9, CI 3.6-202.4, p < .01). These results are illustrated in Fig. 1a .
We found a high correlation between NIHSS at admission and 6-month mRS (rank correlation coefficient = .72, p < .01). Sensitivity was 87.3% (76. 5 curves at 6-month follow-up showed fitted areas as .886 (Fig.  1b) .
Summing up, our results largely confirm findings from Finocchi et al. (2018), but extending their validity to a longer follow-up period. Noteworthy, the baseline characteristics of our patients were similar to Finocchi's patients (mean age 75.2 with prevalence of females), but the mean NIHSS score at admission were higher (12.4 ± 9.7 vs 10.82 ± 8.27) with a similar mortality (32.6% at 6 months vs 34.6% at 3 months).
Although clinical evaluation on posterior circulation stroke remains still a limit of NIHSS, it is a practical scale model, with high reproducibility between different examiners [2] . The NIHSS is associated with final outcome after an ischemic stroke in terms of length of stay, survival, and discharge destination [3] . We prospectively studied the application of the NIHSS and its prognostic value on mortality and disability at 6 months in patients with spontaneous ICH.
Previous studies suggested that NIHSS is a predictor of poor outcome in ICH with an acceptable sensitivity and specificity [4] [5] [6] [7] . It has also been suggested that even GCS, measuring the level of consciousness, could suffice as an outcome predictor in ICH patients [8] .
Nevertheless, in patients with ICH, the NIHSS has not been validated. However, at variance with ischemic strokes, ICH has higher early mortality and poorer long-term outcomes. The possibility to have an easy predictor of outcomes could facilitate decisions for invasive or supportive care. Other instruments for the clinical evaluation of ICH were proposed in literature: further studies could be useful to compare the prognostic value of the NIHSS with that of other scales.
To conclude, our data confirm that NIHSS is a good predictor of a clinical outcome and mortality in patients with ICH, even after a 6-month period of follow-up. Hence, we believe that, also in patients with ICH as in ischemic group, the assessment of NIHSS score at admission is important to predict the future outcome and for prompt clinical management.
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